{"pmid":32441844,"title":"Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.","text":["Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.","Int J Lab Hematol","Huisman, Albert","Beun, Robert","Sikma, Maaike","Westerink, Jan","Kusadasi, Nuray","32441844"],"journal":"Int J Lab Hematol","authors":["Huisman, Albert","Beun, Robert","Sikma, Maaike","Westerink, Jan","Kusadasi, Nuray"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441844","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/ijlh.13244","locations":["von Willebrand"],"topics":["Diagnosis"],"weight":1,"_version_":1667523504870785025,"score":9.490897,"similar":[{"pmid":32505009,"title":"ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.","text":["ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.","Thromb Res","Escher, R","Breakey, N","Lammle, B","32505009"],"journal":"Thromb Res","authors":["Escher, R","Breakey, N","Lammle, B"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32505009","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.thromres.2020.05.032","locations":["von Willebrand","VIII"],"topics":["Case Report"],"weight":1,"_version_":1668892488358690816,"score":91.46053},{"pmid":32360371,"pmcid":"PMC7192088","title":"Thromboembolic Events in Patients with SARS-CoV-2.","text":["Thromboembolic Events in Patients with SARS-CoV-2.","J Vasc Surg","Ng, Jun Jie","Choong, Andrew M T L","32360371"],"journal":"J Vasc Surg","authors":["Ng, Jun Jie","Choong, Andrew M T L"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360371","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jvs.2020.04.488","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495535546369,"score":50.288383},{"pmid":32489244,"title":"Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.","text":["Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.","Fed Pract","Varatharajah, N","Rajah, Suganthi","32489244"],"journal":"Fed Pract","authors":["Varatharajah, N","Rajah, Suganthi"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489244","source":"PubMed","week":"202023|Jun 01 - Jun 07","weight":0,"_version_":1668623433726951424,"score":45.215782},{"pmid":32311843,"title":"Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.","text":["Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.","In March 2020, the global healthcare system is overwhelmed by patients infected with SARS-CoV-2, which is the cause of the coronavirus pandemic (Covid-2019). A large number of these patients end up in the intensive care units (ICU) with critical illness requiring mechanical ventilation. One of the most important clinical features of the infection is a profound coagulopathy. In a recent cohort study 71% of patients who eventually died matched the ISTH criteria for disseminated intravascular coagulation (DIC), while this percentage was only 0.6% in patients who survived.","Int J Lab Hematol","Beun, Robert","Kusadasi, Nuray","Sikma, Maaike","Westerink, Jan","Huisman, Albert","32311843"],"abstract":["In March 2020, the global healthcare system is overwhelmed by patients infected with SARS-CoV-2, which is the cause of the coronavirus pandemic (Covid-2019). A large number of these patients end up in the intensive care units (ICU) with critical illness requiring mechanical ventilation. One of the most important clinical features of the infection is a profound coagulopathy. In a recent cohort study 71% of patients who eventually died matched the ISTH criteria for disseminated intravascular coagulation (DIC), while this percentage was only 0.6% in patients who survived."],"journal":"Int J Lab Hematol","authors":["Beun, Robert","Kusadasi, Nuray","Sikma, Maaike","Westerink, Jan","Huisman, Albert"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311843","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ijlh.13230","e_drugs":["Heparin"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138491200733186,"score":45.12622},{"pmid":32403033,"title":"Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid.","text":["Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid.","Thromb Res","Zachariah, U","Nair, S C","Goel, A","Balasubramanian, K A","Mackie, I","Elias, E","Eapen, C E","32403033"],"journal":"Thromb Res","authors":["Zachariah, U","Nair, S C","Goel, A","Balasubramanian, K A","Mackie, I","Elias, E","Eapen, C E"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32403033","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.thromres.2020.05.001","locations":["von Willebrand"],"topics":["Treatment"],"weight":1,"_version_":1666714494950178816,"score":43.72918}]}